Evidence map›Paper›PMID 32461552›Full record

ArticleNature communications2020

hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma.

Pauline Herviou, Morgane Le Bras, Leïla Dumas, Corinne Hieblot, Julia Gilhodes, Gianluca Cioci, Jean-Philippe Hugnot, Alfred Ameadan, François Guillonneau, Erik Dassi and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. From development to disease: the neuronal role of hnRNPs through the lens ofFrontiers in cell and developmental biology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Pauline Herviou *Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France.
Morgane Le Bras *Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France.
Leïla DumasCancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France.
Corinne HieblotCancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France.
Julia GilhodesInstitut Universitaire du Cancer de Toulouse-Oncopole, 31100, Toulouse, France.
Gianluca CiociTBI, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
Jean-Philippe HugnotINSERM U1051, Institute for Neurosciences, Hôpital Saint Eloi, Université de Montpellier 2, 34090, Montpellier, France.
Alfred AmeadanPlateforme Protéomique 3P5, Université de Paris, Inserm U1016-institut Cochin, Labex GReX, 22 rue Méchain, 75014, Paris, France.ORCID http://orcid.org/0000-0002-8498-3889
François GuillonneauPlateforme Protéomique 3P5, Université de Paris, Inserm U1016-institut Cochin, Labex GReX, 22 rue Méchain, 75014, Paris, France.ORCID http://orcid.org/0000-0003-1484-4696
Erik DassiDepartment of Cellular, Computational and Integrative Biology (CIBIO), University of Trento Via Sommarive 9, 38123, Trento, Italy. erik.dassi@unitn.it.ORCID http://orcid.org/0000-0003-4487-0449
Anne CammasCancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France. anne.cammas@inserm.fr.ORCID http://orcid.org/0000-0002-3240-9172
Stefania MillevoiCancer Research Center of Toulouse (CRCT), INSERM UMR 1037, 31037, Toulouse, France. stefania.millevoi@inserm.fr.ORCID http://orcid.org/0000-0003-1659-3552
Université Toulouse III - Paul Sabatier · FRInserm · FRCentre National de la Recherche Scientifique · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversity of Trento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA G-quadruplexes (RG4s) are four-stranded structures known to control mRNA translation of cancer relevant genes. RG4 formation is pervasive in vitro but not in cellulo, indicating the existence of poorly characterized molecular machinery that remodels RG4s and maintains them unfolded. Here, we performed a quantitative proteomic screen to identify cytosolic proteins that interact with a canonical RG4 in its folded and unfolded conformation. Our results identified hnRNP H/F as important components of the cytoplasmic machinery modulating the structural integrity of RG4s, revealed their function in RG4-mediated translation and uncovered the underlying molecular mechanism impacting the cellular stress response linked to the outcome of glioblastoma.

Indexed as

G-QuadruplexesBrain NeoplasmsCell Line, TumorDEAD-box RNA HelicasesGene Expression RegulationGenomic InstabilityGlioblastomaHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansRNA, MessengerDEAD-box RNA HelicasesDHX36 protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HRNA, Messenger

Identifiers

PMID32461552
PMCPMC7253433
OpenAlexW3031127341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.